Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

DelMar Pharmaceuticals Inc (NASDAQ:DMPI)

0.8639
Delayed Data
As of Oct 20
 -0.016 / -1.82%
Today’s Change
0.80
Today|||52-Week Range
5.73
-72.91%
Year-to-Date
Institutional investors purchased a net $1.7 million shares of DMPI during the quarter ended June 2017, and now own 8.64% of the total float, a percentage that is typical for companies in the Wholesale Distributors industry.
Individual stakeholders5.07%
Mutual fund holders5.02%
Other institutional3.62%

Largest Quarterly Institutional
Transactions

Chart unavailable

Latest Institutional Activity

Top 10 Owners of DelMar Pharmaceuticals Inc

StockholderStakeShares
owned
Total value ($)Shares
bought / sold
Total
change
Franklin Advisers, Inc.5.00%1,076,923904,615+1,076,923--
Sabby Capital LLC3.00%645,390542,128+645,390--
Raymond James Financial Services ...0.60%128,580108,007-1,000-0.77%
BMO Asset Management Corp.0.04%8,5247,16000.00%
UBS Securities LLC0.01%2,8382,384+2,838--
Goldman Sachs & Co. LLC (Private ...0.00%00-10,935-100.00%
Acrospire Investment Management L...0.00%00-50-100.00%

Top 10 Mutual Funds Holding DelMar Pharmaceuticals Inc

Mutual fundStakeShares
owned
Total value ($)Shares
bought / sold
Total
change
FTIF SICAV - Biotechnology Discov...3.19%688,153578,049+688,153--
Franklin Biotechnology Discovery ...1.80%388,770326,567+388,770--
Fidelity Nasdaq Composite Index F...0.02%4,5003,78000.00%